Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2021 16:05 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021

DEER PARK, Ill., May 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
March 17, 2021 16:05 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors

DEER PARK, Ill., March 17, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
March 16, 2021 16:02 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results

DEER PARK, Ill., March 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
March 04, 2021 16:05 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16, 2021

DEER PARK, Ill., March 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
February 16, 2021 16:05 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference

DEER PARK, Ill., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
February 08, 2021 08:00 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces Sale of Neurology Portfolio

Eton to receive up to $45 million plus royalties on product sales DEER PARK, Ill., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company...
January 14, 2021 08:00 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE

DEER PARK, Ill., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
December 17, 2020 08:00 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Topiramate Oral Solution

DEER PARK, Ill., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
November 24, 2020 09:00 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDI® SPRINKLE (hydrocortisone) in the United States

ALKINDI® SPRINKLE is now exclusively available through AnovoRx Specialty Pharmacy. To support patient access to ALKINDI® SPRINKLE, Eton has established the Eton Cares Program®. DEER PARK, Ill., Nov....
November 12, 2020 16:05 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces Third Quarter 2020 Financial Results

DEER PARK, Ill., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right